Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?"

J Allergy Clin Immunol Pract. 2021 Jul;9(7):2943-2944. doi: 10.1016/j.jaip.2021.04.029.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Churg-Strauss Syndrome* / diagnosis
  • Churg-Strauss Syndrome* / drug therapy
  • Granulomatosis with Polyangiitis* / diagnosis
  • Granulomatosis with Polyangiitis* / drug therapy
  • Humans
  • Interleukin-5

Substances

  • Antibodies, Monoclonal, Humanized
  • Interleukin-5
  • mepolizumab